MRGPRX3
gene geneOn this page
Also known as MRGX3
Summary
MRGPRX3 (MAS related GPR family member X3, HGNC:17980) is a protein-coding gene on chromosome 11p15.1, encoding Mas-related G-protein coupled receptor member X3 (Q96LB0). Orphan receptor.
This gene encodes a member of the mas-related/sensory neuron specific subfamily of G protein coupled receptors. The encoded protein may be involved in sensory neuron regulation and in the modulation of pain.
Source: NCBI Gene 117195 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 95 total
- Druggable target: yes
- MANE Select transcript:
NM_001370464
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:17980 |
| Approved symbol | MRGPRX3 |
| Name | MAS related GPR family member X3 |
| Location | 11p15.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MRGX3 |
| Ensembl gene | ENSG00000179826 |
| Ensembl biotype | protein_coding |
| OMIM | 607229 |
| Entrez | 117195 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000396275, ENST00000621697
RefSeq mRNA: 2 — MANE Select: NM_001370464
NM_001370464, NM_054031
CCDS: CCDS7830
Canonical transcript exons
ENST00000621697 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003742132 | 18137178 | 18138488 |
| ENSE00003749219 | 18132571 | 18132739 |
Expression profiles
Bgee: expression breadth broad, 25 present calls, max score 56.83.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.3626 / max 34.3212, expressed in 109 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 113303 | 0.3203 | 100 |
| 113302 | 0.0423 | 22 |
Top tissues by expression
225 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| minor salivary gland | UBERON:0001830 | 56.83 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 55.58 | gold quality |
| mouth mucosa | UBERON:0003729 | 54.67 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 53.64 | gold quality |
| esophagus mucosa | UBERON:0002469 | 46.89 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 46.21 | gold quality |
| bone marrow cell | CL:0002092 | 45.09 | gold quality |
| upper leg skin | UBERON:0004262 | 44.01 | silver quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 43.76 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 42.14 | gold quality |
| vastus lateralis | UBERON:0001379 | 41.41 | gold quality |
| quadriceps femoris | UBERON:0001377 | 41.37 | gold quality |
| superficial temporal artery | UBERON:0001614 | 41.33 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 41.10 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 40.98 | gold quality |
| colonic epithelium | UBERON:0000397 | 40.93 | gold quality |
| thoracic mammary gland | UBERON:0005200 | 40.89 | gold quality |
| mammary gland | UBERON:0001911 | 40.88 | gold quality |
| amniotic fluid | UBERON:0000173 | 40.69 | gold quality |
| jejunal mucosa | UBERON:0000399 | 40.59 | gold quality |
| biceps brachii | UBERON:0001507 | 40.57 | gold quality |
| sural nerve | UBERON:0015488 | 40.56 | gold quality |
| stromal cell of endometrium | CL:0002255 | 40.55 | silver quality |
| epithelium of nasopharynx | UBERON:0001951 | 40.45 | gold quality |
| myocardium | UBERON:0002349 | 40.45 | gold quality |
| gingival epithelium | UBERON:0001949 | 40.43 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 40.33 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 40.29 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-7 | yes | 991.13 |
| E-ENAD-21 | yes | 770.91 |
| E-ANND-3 | no | 1.78 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
34 targeting MRGPRX3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-10523-5P | 99.91 | 69.22 | 2038 |
| HSA-MIR-106A-5P | 99.90 | 73.94 | 2683 |
| HSA-MIR-17-5P | 99.89 | 73.83 | 2665 |
| HSA-MIR-106B-5P | 99.88 | 74.72 | 2795 |
| HSA-MIR-20A-5P | 99.88 | 74.76 | 2769 |
| HSA-MIR-20B-5P | 99.88 | 74.01 | 2621 |
| HSA-MIR-519D-3P | 99.88 | 73.97 | 2607 |
| HSA-MIR-526B-3P | 99.88 | 74.06 | 2587 |
| HSA-MIR-93-5P | 99.88 | 73.98 | 2606 |
| HSA-MIR-12119 | 99.87 | 68.35 | 1653 |
| HSA-MIR-548AZ-5P | 99.83 | 69.94 | 3230 |
| HSA-MIR-548T-5P | 99.83 | 69.91 | 3220 |
| HSA-MIR-448 | 99.79 | 72.37 | 2103 |
| HSA-MIR-3129-5P | 99.75 | 70.46 | 914 |
| HSA-MIR-148A-3P | 99.74 | 73.77 | 1700 |
| HSA-MIR-148B-3P | 99.74 | 73.75 | 1700 |
| HSA-MIR-152-3P | 99.74 | 73.75 | 1703 |
| HSA-MIR-4255 | 99.72 | 67.70 | 1541 |
| HSA-MIR-519A-3P | 99.67 | 71.67 | 1868 |
| HSA-MIR-519B-3P | 99.67 | 71.67 | 1868 |
| HSA-MIR-519C-3P | 99.67 | 71.67 | 1870 |
| HSA-MIR-5700 | 99.64 | 69.88 | 2280 |
| HSA-MIR-1827 | 99.63 | 68.57 | 3265 |
| HSA-MIR-298 | 99.63 | 67.56 | 1916 |
| HSA-MIR-4649-3P | 99.56 | 66.90 | 1783 |
| HSA-MIR-548AV-3P | 99.43 | 68.50 | 1721 |
| HSA-MIR-889-3P | 99.40 | 69.76 | 2103 |
| HSA-MIR-8065 | 99.19 | 70.38 | 1289 |
| HSA-MIR-222-5P | 98.75 | 69.17 | 1242 |
| HSA-MIR-1262 | 98.17 | 66.52 | 757 |
Literature-anchored findings (GeneRIF, showing 4)
- overexpression of the human MrgX3 gene causes a disturbance of the normal cell-differentiation process (PMID:15809047)
- Potential of GPCRs to modulate MAPK and mTOR pathways in different stages of the neurodegenerative disease. (PMID:28189739)
- Our data demonstrate that GPR182 is an endothelial subtype-specific marker for human sinusoidal EC of the liver, spleen, lymph node and bone marrow. In addition, we provide evidence for GPR182-dependent downstream signaling via ERK and SRF pathways that may be involved in regulating endothelial subtype-specific sinusoidal differentiation and sinusoidal functions such as permeability. (PMID:29408502)
- GPCR-mediated EGFR transactivation ameliorates skin toxicities induced by afatinib. (PMID:34552215)
Cross-species orthologs
26 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Mrgprb2 | ENSMUSG00000050425 |
| mus_musculus | Mrgpra1 | ENSMUSG00000050650 |
| mus_musculus | Mrgprb8 | ENSMUSG00000050870 |
| mus_musculus | Mrgpra6 | ENSMUSG00000052303 |
| mus_musculus | Mrgpra4 | ENSMUSG00000067173 |
| mus_musculus | Mrgprb3 | ENSMUSG00000070546 |
| mus_musculus | Mrgprb1 | ENSMUSG00000070547 |
| mus_musculus | Mrgprb4 | ENSMUSG00000070550 |
| mus_musculus | Mrgprb5 | ENSMUSG00000070551 |
| mus_musculus | Mrgprx1 | ENSMUSG00000070552 |
| mus_musculus | Mrgprx2 | ENSMUSG00000074109 |
| mus_musculus | Mrgpra9 | ENSMUSG00000074111 |
| mus_musculus | Mrgpra3 | ENSMUSG00000078698 |
| mus_musculus | Mrgpra2a | ENSMUSG00000093973 |
| mus_musculus | Mrgpra2b | ENSMUSG00000096719 |
| rattus_norvegicus | Mrgprx3 | ENSRNOG00000014227 |
| rattus_norvegicus | Mrgprx1 | ENSRNOG00000014242 |
| rattus_norvegicus | Mrgprb3l | ENSRNOG00000014266 |
| rattus_norvegicus | Mrgprb5 | ENSRNOG00000022703 |
| rattus_norvegicus | Mrgprx2l | ENSRNOG00000022729 |
| rattus_norvegicus | Mrgprb3 | ENSRNOG00000028982 |
| rattus_norvegicus | Mrgprb4 | ENSRNOG00000033021 |
| rattus_norvegicus | Mrgprb2 | ENSRNOG00000037156 |
| rattus_norvegicus | Mrgprb13 | ENSRNOG00000074277 |
| rattus_norvegicus | ENSRNOG00000081169 | |
| rattus_norvegicus | ENSRNOG00000084911 |
Paralogs (10): MAS1 (ENSG00000130368), MRGPRX1 (ENSG00000170255), MRGPRF (ENSG00000172935), MRGPRD (ENSG00000172938), GPR152 (ENSG00000175514), MRGPRX4 (ENSG00000179817), MRGPRG (ENSG00000182170), MRGPRX2 (ENSG00000183695), MRGPRE (ENSG00000184350), MAS1L (ENSG00000204687)
Protein
Protein identifiers
Mas-related G-protein coupled receptor member X3 — Q96LB0 (reviewed: Q96LB0)
Alternative names: Sensory neuron-specific G-protein coupled receptor 1/2
All UniProt accessions (1): Q96LB0
UniProt curated annotations — full annotation on UniProt →
Function. Orphan receptor. Probably involved in the function of nociceptive neurons. May regulate nociceptor function and/or development, including the sensation or modulation of pain. Potently activated by enkephalins.
Subcellular location. Cell membrane.
Tissue specificity. Uniquely localized in a subset of small dorsal root and trigeminal sensory neurons.
Similarity. Belongs to the G-protein coupled receptor 1 family. Mas subfamily.
RefSeq proteins (2): NP_001357393, NP_473372 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
| IPR026234 | MRGPCRFAMILY | Family |
Pfam: PF00001
UniProt features (32 total): sequence conflict 14, topological domain 8, transmembrane region 7, sequence variant 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96LB0-F1 | 81.99 | 0.50 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 17 (showing top):
BILD_HRAS_ONCOGENIC_SIGNATURE, DOUGLAS_BMI1_TARGETS_DN, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, MIR148A_3P, MIR152_3P, MIR148B_3P, MIR5700, MIR10523_5P, BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP, BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_UP, GSE29615_CTRL_VS_DAY3_LAIV_IFLU_VACCINE_PBMC_UP, GOMF_MOLECULAR_TRANSDUCER_ACTIVITY, GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_DN
GO Biological Process (2): G protein-coupled receptor signaling pathway (GO:0007186), signal transduction (GO:0007165)
GO Molecular Function (2): G protein-coupled receptor activity (GO:0004930), protein binding (GO:0005515)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| transmembrane signaling receptor activity | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| binding | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
262 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MRGPRX3 | NPFF | O15130 | 851 |
| MRGPRX3 | TMEM69 | Q5SWH9 | 464 |
| MRGPRX3 | TRPA1 | O75762 | 411 |
| MRGPRX3 | CCDC137 | Q6PK04 | 407 |
| MRGPRX3 | CLRN1 | P58418 | 398 |
| MRGPRX3 | ARRB2 | P32121 | 376 |
| MRGPRX3 | C1QTNF7 | Q9BXJ2 | 373 |
| MRGPRX3 | HTR1D | P28221 | 373 |
| MRGPRX3 | TRPM8 | Q7Z2W7 | 365 |
| MRGPRX3 | TAS2R38 | P59533 | 353 |
| MRGPRX3 | ZP4 | Q12836 | 353 |
| MRGPRX3 | SPICE1 | Q8N0Z3 | 342 |
| MRGPRX3 | CYYR1 | Q96J86 | 338 |
| MRGPRX3 | MORF4L2 | Q15014 | 336 |
| MRGPRX3 | MAB21L4 | Q08AI8 | 331 |
IntAct
11 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TTMP | MRGPRX3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RAMP1 | MRGPRX3 | psi-mi:“MI:0915”(physical association) | 0.400 |
| MRGPRX3 | RAMP1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| MRGPRX3 | RAMP2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| RAMP2 | MRGPRX3 | psi-mi:“MI:0915”(physical association) | 0.400 |
| RAMP3 | MRGPRX3 | psi-mi:“MI:0915”(physical association) | 0.400 |
| KLHL22 | TRAV18 | psi-mi:“MI:0914”(association) | 0.350 |
| TTMP | MRGPRX3 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (2): MRGPRX3 (Two-hybrid), MRGPRX3 (Affinity Capture-MS)
ESM2 similar proteins: Q2LL16, Q3KNA1, Q3UG50, Q3UG61, Q4QXU0, Q4QXU2, Q4QXU3, Q4QXU4, Q4QXU5, Q4QXU6, Q4QXX9, Q5U9D9, Q645T2, Q645T7, Q645V2, Q645V8, Q645Z2, Q646A2, Q646C4, Q646D6, Q646F4, Q646F6, Q67ES0, Q6L786, Q7TN39, Q7TN41, Q7TN44, Q7TN45, Q7TN49, Q7TN50, Q86SM5, Q8CIP3, Q8R4G1, Q8TDS7, Q91WW2, Q91WW3, Q91WW4, Q91WW5, Q91ZB5, Q91ZB9
Diamond homologs: B9VR26, O55197, O88680, P04201, P12526, P23749, P30554, P35410, Q16581, Q2LL16, Q3KNA1, Q3UG50, Q3UG61, Q4QXU0, Q4QXU2, Q4QXU3, Q4QXU4, Q4QXU5, Q4QXU6, Q4QXX9, Q5REI5, Q5U9D9, Q6L786, Q6TAC8, Q6XKD3, Q7TN38, Q7TN39, Q7TN40, Q7TN41, Q7TN44, Q7TN45, Q7TN49, Q7TN50, Q7TN51, Q86SM5, Q8CIP3, Q8NGA4, Q8R4G1, Q8TDS7, Q8VCJ6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
95 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 85 |
| Likely benign | 9 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
676 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:18137173:TCCA:T | acceptor_loss | 1.0000 |
| 11:18137174:CCA:C | acceptor_loss | 1.0000 |
| 11:18137175:CA:C | acceptor_loss | 1.0000 |
| 11:18137176:A:AC | acceptor_loss | 1.0000 |
| 11:18137176:A:AG | acceptor_gain | 1.0000 |
| 11:18137176:AG:A | acceptor_gain | 1.0000 |
| 11:18137177:G:GG | acceptor_gain | 1.0000 |
| 11:18137177:GG:G | acceptor_gain | 1.0000 |
| 11:18137177:GGGTC:G | acceptor_gain | 1.0000 |
| 11:18121279:G:GT | donor_gain | 0.9900 |
| 11:18121279:G:T | donor_gain | 0.9900 |
| 11:18137176:AGG:A | acceptor_gain | 0.9900 |
| 11:18137177:GGG:G | acceptor_gain | 0.9900 |
| 11:18137177:GGGT:G | acceptor_gain | 0.9900 |
| 11:18121046:G:GT | donor_gain | 0.9800 |
| 11:18121006:G:GT | donor_gain | 0.9700 |
| 11:18121092:G:T | donor_gain | 0.9700 |
| 11:18121242:G:GG | donor_gain | 0.9700 |
| 11:18121282:G:GG | donor_gain | 0.9700 |
| 11:18121288:A:T | donor_gain | 0.9700 |
| 11:18121323:G:T | donor_gain | 0.9700 |
| 11:18137169:T:TA | acceptor_gain | 0.9700 |
| 11:18121239:G:GT | donor_gain | 0.9600 |
| 11:18121239:GAA:G | donor_gain | 0.9600 |
| 11:18121403:G:T | donor_gain | 0.9600 |
| 11:18132610:TCAG:T | acceptor_gain | 0.9600 |
| 11:18132611:CAGC:C | acceptor_gain | 0.9600 |
| 11:18132613:G:T | acceptor_gain | 0.9600 |
| 11:18121204:G:T | donor_gain | 0.9500 |
| 11:18132612:AG:A | acceptor_gain | 0.9500 |
AlphaMissense
2077 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:18137875:T:C | F225L | 0.876 |
| 11:18137877:C:A | F225L | 0.876 |
| 11:18137877:C:G | F225L | 0.876 |
| 11:18137542:A:C | S114R | 0.813 |
| 11:18137544:C:A | S114R | 0.813 |
| 11:18137544:C:G | S114R | 0.813 |
| 11:18137785:A:C | S195R | 0.775 |
| 11:18137787:C:A | S195R | 0.775 |
| 11:18137787:C:G | S195R | 0.775 |
| 11:18137551:A:C | S117R | 0.759 |
| 11:18137553:C:A | S117R | 0.759 |
| 11:18137553:C:G | S117R | 0.759 |
| 11:18137533:A:C | S111R | 0.734 |
| 11:18137535:C:A | S111R | 0.734 |
| 11:18137535:C:G | S111R | 0.734 |
| 11:18138019:T:C | F273L | 0.712 |
| 11:18138021:C:A | F273L | 0.712 |
| 11:18138021:C:G | F273L | 0.712 |
| 11:18137998:A:C | S266R | 0.689 |
| 11:18138000:T:A | S266R | 0.689 |
| 11:18138000:T:G | S266R | 0.689 |
| 11:18137641:T:A | W147R | 0.682 |
| 11:18137641:T:C | W147R | 0.682 |
| 11:18138034:T:C | F278L | 0.663 |
| 11:18138036:T:A | F278L | 0.663 |
| 11:18138036:T:G | F278L | 0.663 |
| 11:18137425:T:C | F75L | 0.630 |
| 11:18137427:C:A | F75L | 0.630 |
| 11:18137427:C:G | F75L | 0.630 |
| 11:18137431:A:C | S77R | 0.610 |
dbSNP variants (sampled 300 via entrez): RS1000034070 (11:18124905 G>A,C), RS1000076297 (11:18135603 G>A,T), RS1000122906 (11:18124360 C>T), RS1000239421 (11:18124172 C>T), RS1000414119 (11:18122019 G>A,C), RS1000636399 (11:18126556 T>A), RS1000678755 (11:18129431 A>T), RS1000705385 (11:18138610 G>A), RS1000899978 (11:18127029 A>G), RS1000901806 (11:18133547 G>A), RS1001257228 (11:18135995 C>G), RS1001326945 (11:18138816 C>T), RS1001449750 (11:18119361 T>TG), RS1001557015 (11:18119640 AG>A), RS1002342018 (11:18119842 C>T)
Disease associations
OMIM: gene MIM:607229 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL4523905 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: gpcr — Class A Orphans with no pharmacology
CTD chemical–gene interactions
10 total (human), top 10 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| terbufos | increases methylation | 1 |
| sodium arsenite | increases expression | 1 |
| abrine | increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Fonofos | increases methylation | 1 |
| Estradiol | affects cotreatment, increases expression | 1 |
| Parathion | increases methylation | 1 |
| Quercetin | increases expression | 1 |
| Asbestos, Serpentine | affects expression | 1 |
| Asbestos, Crocidolite | affects expression | 1 |
ChEMBL screening assays
3 unique, capped per target: 2 binding, 1 functional
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL4883537 | Binding | PRESTO-Tango GPCRome screening (MRGPRX3) | Data for DCP probe UCSF924 |
| CHEMBL5376125 | Functional | Agonist activity at MRGPRX3 (unknown origin) by beta-arrestin recruitment assay | Discovery of Potent Agonists for the Predominant Variant of the Orphan MAS-Related G Protein-Coupled Receptor X4 (MRGPRX4). — J Med Chem |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.